Back to search

Oxular Acquisitions Limited

12798969

active
ltd
england wales
Companies House
Health Score
65 / 100

Some Concerns

25/30
Filing
0/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)
  • Negative net worth (-10)
  • Current liabilities exceed current assets (-10)

Details

The Charter Building, Vine Street, Uxbridge, UB8 1JG
Incorporated 07/08/2020

Compliance

Last accounts

31/10/2024

micro entity

Next accounts due

30/09/2026

On track

Confirmation statement

Last: 03/08/2026

Due 17/08/2027

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Mark Volpe

director · Since 20/12/2024

SENIOR VICE PRESIDENT

AMERICAN · UNITED STATES · Age 54

Also on 2 other boards

Zoran Berkovic

director · Since 20/12/2024

SENIOR VICE PRESIDENT

AMERICAN · UNITED STATES · Age 49

Also on 2 other boards

Zoran Berkovic

director · Since 20/12/2024

American · United States · Age 49

Mark Volpe

director · Since 20/12/2024

American · United States · Age 54

Former

Ronald Yamamoto

director · Resigned 27/01/2022

Dina Chaya Moghrabi

director · Resigned 31/01/2023

Thomas Cavanagh

director · Resigned 31/07/2023

Christina Takke

director · Resigned 20/12/2024

Ip2ipo Services Limited

corporate director · Resigned 20/12/2024

David Fellows

director · Resigned 20/12/2024

Kenneth Macleod

director · Resigned 20/12/2024

Mark William-Semrau Gaffney

director · Resigned 20/12/2024

Persons with Significant Control

Oxular Limited

75–100% shares
75–100% votes
Appoint directors

6th Floor, One London Wall, London, EC2Y 5EB

Reg: 09331313 · Companies House · Limited By Shares

Notified 07/08/2020

Regeneron Pharmaceuticals, Inc

75–100% shares
75–100% votes
Appoint directors

777, Old Saw Mill River Road, Tarrytown

Reg: 1226128 · New York State Department Of State'S Division Of Corporations · New York Corporation

Notified 20/11/2024

Change History

statusactive
2026-07-17

Active

typeltd
2026-07-17

Private Limited Company

address line1The Charter Building
2026-07-17

THE CHARTER BUILDING

post townUxbridge
2026-07-17

UXBRIDGE

CompanyRankvs 3460+ SIC 72110 peers
27

Financial strength5th percentile among SIC peers · 1/25
Employees22th percentile among SIC peers · 3/15
LiquidityCurrent ratio 0× · 2/20
Longevity6 years trading (max 15) · 6/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength1/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees3/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity6/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/10/2023

Net Worth

-£467k

Balance sheet strength

Cash

£25

Cash in the bank

Net Current Assets

-£467k

Working capital

Current Assets

£25

Current Liabilities

£467k

Profit After Tax

-£53k

0avg. employees

Balance Sheet

Assets less current liabilities-£467k
Prepared with Caseware UK (AP4) 2022.0.179

EstimatesDerived

YearCurrent Ratio
20230.00

Derived from filed accounts. Not audited figures.